Voloridge Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-239,832
| Closed | -$2.74M | – | 1249 |
|
|
2023
Q4 | $2.74M | Buy |
239,832
+126,235
| +111% | +$1.44M | 0.01% | 758 |
|
|
2023
Q3 | $1.09M | Sell |
113,597
-793,328
| -87% | -$7.64M | 0.01% | 1077 |
|
|
2023
Q2 | $9.65M | Buy |
906,925
+557,088
| +159% | +$5.93M | 0.05% | 468 |
|
|
2023
Q1 | $3.68M | Buy |
349,837
+222,291
| +174% | +$2.34M | 0.02% | 780 |
|
|
2022
Q4 | $1.58M | Buy |
+127,546
| New | +$1.58M | 0.01% | 1030 |
|
|
2022
Q3 | – | Sell |
-240,431
| Closed | -$2.77M | – | 1507 |
|
|
2022
Q2 | $2.77M | Buy |
240,431
+215,797
| +876% | +$2.49M | 0.01% | 901 |
|
|
2022
Q1 | $310K | Buy |
+24,634
| New | +$310K | ﹤0.01% | 1267 |
|
|
2021
Q2 | – | Sell |
-127,473
| Closed | -$1.43M | – | 1690 |
|
|
2021
Q1 | $1.43M | Buy |
127,473
+94,957
| +292% | +$1.06M | 0.01% | 925 |
|
|
2020
Q4 | $370K | Buy |
+32,516
| New | +$370K | ﹤0.01% | 1184 |
|
|
2020
Q2 | – | Sell |
-12,546
| Closed | -$127K | – | 1378 |
|
|
2020
Q1 | $127K | Sell |
12,546
-24,679
| -66% | -$250K | ﹤0.01% | 1013 |
|
|
2019
Q4 | $495K | Buy |
+37,225
| New | +$495K | 0.01% | 816 |
|